出处
《重庆医学》
CAS
CSCD
2002年第8期694-696,共3页
Chongqing medicine
基金
国家自然科学基金重大项目 (39993430 2 )
国家自然科学基金面上项目 (39970 756)
国家科技部重点项目 (96 92 0 2 0 1 0 )
全军医药重点项目 (98Z0 81 )
参考文献15
-
1[1]Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation[J].Annu Rev Immunol,1996,14:233 .
-
2[2]Guerder S, Flavell RA. Costimulation in tolerance and auto immunity[J].Int Rev Immunol,1995,13(2):135.
-
3[3]Croft M, Dubey C. Accessory molecule and costimulation req uirements for CD4 T cell response[J]. Crit Rev Immunol,1997,17(1):89.
-
4[4]Guerder S, Flavell RA. Costimulation in tolerance and auto immunity[J].Int Rev Immunol,1995,13(2):135.
-
5[5]Ellis JH, Burden MN, Vinogradov DV, et al. Interactions of CD80 and CD86 with CD28 and CTLA4[J].J Immunol,1996,156(8):2700 .
-
6[6]Linsley PS, Wallace PM, Johnson J, et al. Immunosuppressio n in vivo by a soluble form of the CTLA4 T cell activation molecule[J].Scicenc e,1992,257(5701):792 .
-
7[7]Guillot C, Mathieu P, Coathalem H, et al. Tolerance to car diac allografts via local and systemic mechanisms after adenovirus-mediated CTL A4Ig expression[J]. J Immunol,2000,164(10):5258.
-
8[8]Kita Y, Li XK, Ohba M, et al. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-ge ne[J].Transplantation,1999,68(6):758 .
-
9[9]Tomasoni S, Azzollini N,Casiraghi F, et al. CTLA4Ig gene transfer prolongs survival and induce donor specific tolerance in a rat renal al lograft[J]. J Am Soc Nephrol,2000,11:747.
-
10[10]Ijima K, Murakami M, Okamoto H, et al. Successful gene th erapy via intraarticular injection of adenovirus vector containing CTLA4Ig G in a murine model of type Ⅱ collagen-induced arthritis[J]. Hum Gene Ther,2001, 12(9):1063.
同被引文献8
-
1陈陵,向国春,李向红,蔡永国,李晶晶,房殿春,罗元辉,李志宏,杨仕明.负载hTERT复制缺陷型腺病毒的包装及鉴定[J].第四军医大学学报,2006,27(1):53-56. 被引量：7
-
2Piconi S,Trabattoni D,Saresella M,et al.Effects of specific immunotherapy on the B7 family of costimulatory molecules in allergic inflammation[J].J Immunol,2007,178(3):1931-1937.
-
3Ellis JH,Burden MN,Vinogradov DV,et al.Interactions of CD80 and CD86 with CD28 and CTLA4[J].J Immunol,1996,156(8):2700.
-
4He TC,Zhou S,Da Costa LT,et a1.A simplified system for generating recombinant adenoviruses[J].Proc Natl Acad Sci USA,1998,95:2509-2514.
-
5Seveno C,Coulon F,Haspot F,et,al.Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation[J].Xenotransplantation,2007,14(1):25-33.
-
6Crow MK.Modification of accessory molecule signaling[J].Springer Semin Immunopathol,2006,27(4):409-424.
-
7Mossoba ME,Medin JA.Cancer immunotherapy using virally transduced dendritic cells.Animal studies and human clinical trials[J].Expert Rev Vaccines,2006 Oct;5(5):717-732.
-
8Kay MA,Holterman AX,Meuse L,et,al.Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration[J].Nat Genet,1995,11(2):191-197.
二级引证文献2
-
1白枫,黎海芪.黄褐毛忍冬总皂苷对卵清蛋白致敏小鼠的抗过敏作用[J].第四军医大学学报,2008,29(15):1395-1398. 被引量：14
-
2齐宗利,李慧瑾,王东阳,赵俊丽,边晔,冯真真,蒋羽清,郑晓晶,夏海滨.人canstatin基因重组腺病毒载体的构建及其病毒制备[J].第四军医大学学报,2008,29(18):1637-1640. 被引量：3
-
1田普训,吴军,李钊伦,薛武军,丁小明,贺伟峰,易绍萱,陈希伟.重组腺病毒介导CD40L和CTLA4Ig的共表达和对人混合淋巴细胞反应的抑制作用[J].中华器官移植杂志,2005,26(11):694-695.
-
2叶启翔,翁文俊,许吕宏,方建培.阻断共刺激信号途径对造血干细胞移植后致敏受者免疫耐受排斥的影响[J].中国实验血液学杂志,2014,22(1):131-135. 被引量：2
-
3王珍祥,吴军,陈希炜,易绍萱.CTLA4Ig表达质粒的基因枪转染皮肤及细胞的实验研究[J].重庆医学,2002,31(8):661-662. 被引量：1
-
4杨毅,韩义香,章圣辉,李秉煦.银屑病患者外周血T淋巴细胞CD40／CD40L表达上调[J].中华皮肤科杂志,2008,41(3):186-187. 被引量：2
-
5黄海雯,傅晋翔.CD40-CD40L在血液病中的作用[J].国外医学（输血及血液学分册）,2003,26(1):60-62. 被引量：1
-
6王吉刚,梁后杰,史曦凯,陈洁平,罗高兴.CTLA4Ig基因修饰的BMSCs支持CD34^+细胞扩增的实验研究[J].免疫学杂志,2003,19(2):121-126. 被引量：3
-
7益赛普治疗银屑病征文通知[J].中华皮肤科杂志,2015,48(11):821-821.
-
8益赛普治疗银屑病征文通知[J].中华皮肤科杂志,2015,48(6):377-377.
-
9史曦凯,王吉刚,梁后杰,张翼军,陈洁平,夏顺中,罗高兴.腺病毒介导CTLA4Ig基因修饰的骨髓基质细胞诱导特异性免疫耐受的实验研究[J].重庆医学,2002,31(9):840-842. 被引量：2
-
10益赛普治疗银屑病征文通知[J].中华皮肤科杂志,2015,48(7):466-466.
